Semeglutide is not approved domestically for weight loss. It is only approved for use in patients with type 2 diabetes, is a hypoglycemic drug, and has the effect of reducing major cardiovascular adverse events.
The most common adverse reactions are gastrointestinal discomfort, including nausea, vomiting, diarrhea, abdominal pain, dyspepsia, constipation, and decreased appetite. If you are really obese, please consult a professional doctor, scientific management of weight is a healthy way to maintain a healthy figure.